pH-sensitive anti-CTLA4 antibodies: yes to efficacy, no to toxicity
Crossref DOI link: https://doi.org/10.1038/s41422-019-0198-8
Published Online: 2019-07-12
Published Print: 2019-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Altman, Amnon
Kong, Kok-Fai
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA233862)
Text and Data Mining valid from 2019-07-12
Version of Record valid from 2019-07-12
Article History
First Online: 12 July 2019